Literature DB >> 34302897

Drug delivery carriers with therapeutic functions.

Shuting S Cai1, Tianyu Li1, Tolulope Akinade2, Yuefei Zhu1, Kam W Leong3.   

Abstract

Design of micro- or nanocarriers for drug delivery has primarily been focused on properties such as hydrophobicity, biodegradability, size, shape, surface charge, and toxicity, so that they can achieve optimal delivery with respect to drug loading, release kinetics, biodistribution, cellular uptake, and biocompatibility. Incorporation of stimulus-sensitive moieties into the carriers would lead to "smart" delivery systems. A further evolution would be to endow the carrier with a therapeutic function such that it no longer serves as a mere passive entity to release the drug at the target tissue but can be viewed as a therapeutic agent in itself. In this review, we will discuss recent and ongoing efforts over the past decade to design therapeutic drug carriers that confer a biological benefit, including ROS scavenging or generating, pro- or anti-inflammatory, and immuno-evasive properties, to enhance the overall therapeutic efficacy of the delivery systems.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anti-bacterial; Anti-fibrotic; Anti-inflammatory; Anti-microbial; Drug delivery; Immunoadjuvant; ROS generation; ROS scavenging; Therapeutic carriers

Mesh:

Substances:

Year:  2021        PMID: 34302897      PMCID: PMC8440421          DOI: 10.1016/j.addr.2021.113884

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   17.873


  133 in total

1.  Modulation of Immune Responses by Particulate Materials.

Authors:  Filipa Lebre; Claire H Hearnden; Ed C Lavelle
Journal:  Adv Mater       Date:  2016-05-11       Impact factor: 30.849

Review 2.  Engineering the drug carrier biointerface to overcome biological barriers to drug delivery.

Authors:  Joel A Finbloom; Flávia Sousa; Molly M Stevens; Tejal A Desai
Journal:  Adv Drug Deliv Rev       Date:  2020-06-11       Impact factor: 15.470

Review 3.  Antifibrotic strategies for medical devices.

Authors:  Nicholas G Welch; David A Winkler; Helmut Thissen
Journal:  Adv Drug Deliv Rev       Date:  2020-06-15       Impact factor: 15.470

4.  Diselenide-Pemetrexed Assemblies for Combined Cancer Immuno-, Radio-, and Chemotherapies.

Authors:  Tianyu Li; Shuojiong Pan; Shiqian Gao; Wentian Xiang; Chenxing Sun; Wei Cao; Huaping Xu
Journal:  Angew Chem Int Ed Engl       Date:  2020-01-03       Impact factor: 15.336

5.  Chitosan-g-MPEG-modified alginate/chitosan hydrogel microcapsules: a quantitative study of the effect of polymer architecture on the resistance to protein adsorption.

Authors:  Jia N Zheng; Hong G Xie; Wei T Yu; Xiu D Liu; Wei Y Xie; Jing Zhu; Xiao J Ma
Journal:  Langmuir       Date:  2010-10-15       Impact factor: 3.882

Review 6.  An insight into anti-inflammatory effects of natural polysaccharides.

Authors:  Chunyan Hou; Lili Chen; Liuzhi Yang; Xiaolong Ji
Journal:  Int J Biol Macromol       Date:  2020-02-27       Impact factor: 6.953

7.  Biodistribution and in vivo activities of tumor-associated macrophage-targeting nanoparticles incorporated with doxorubicin.

Authors:  Mengmeng Niu; Youssef W Naguib; Abdulaziz M Aldayel; Yan-chun Shi; Stephen D Hursting; Matthew A Hersh; Zhengrong Cui
Journal:  Mol Pharm       Date:  2014-10-27       Impact factor: 4.939

8.  In vitro antibacterial activity of poly (amidoamine)-G7 dendrimer.

Authors:  Mitra Gholami; Rashin Mohammadi; Mohsen Arzanlou; Fakhraddin Akbari Dourbash; Ebrahim Kouhsari; Gharib Majidi; Seyed Mohsen Mohseni; Shahram Nazari
Journal:  BMC Infect Dis       Date:  2017-06-05       Impact factor: 3.090

Review 9.  Antimicrobial Polymers: The Potential Replacement of Existing Antibiotics?

Authors:  Nor Fadhilah Kamaruzzaman; Li Peng Tan; Ruhil Hayati Hamdan; Siew Shean Choong; Weng Kin Wong; Amanda Jane Gibson; Alexandru Chivu; Maria de Fatima Pina
Journal:  Int J Mol Sci       Date:  2019-06-04       Impact factor: 5.923

10.  Mucosal Immunity and Protective Efficacy of Intranasal Inactivated Influenza Vaccine Is Improved by Chitosan Nanoparticle Delivery in Pigs.

Authors:  Santosh Dhakal; Sankar Renu; Shristi Ghimire; Yashavanth Shaan Lakshmanappa; Bradley T Hogshead; Ninoshkaly Feliciano-Ruiz; Fangjia Lu; Harm HogenEsch; Steven Krakowka; Chang Won Lee; Gourapura J Renukaradhya
Journal:  Front Immunol       Date:  2018-05-02       Impact factor: 7.561

View more
  3 in total

Review 1.  Bone-Targeted Nanoparticle Drug Delivery System: An Emerging Strategy for Bone-Related Disease.

Authors:  Yulin Chen; Xianmin Wu; Jiadong Li; Yingying Jiang; Ke Xu; Jiacan Su
Journal:  Front Pharmacol       Date:  2022-05-31       Impact factor: 5.988

2.  Acoustofluidics for simultaneous nanoparticle-based drug loading and exosome encapsulation.

Authors:  Zeyu Wang; Joseph Rich; Nanjing Hao; Yuyang Gu; Chuyi Chen; Shujie Yang; Peiran Zhang; Tony Jun Huang
Journal:  Microsyst Nanoeng       Date:  2022-04-28       Impact factor: 8.006

3.  Interaction of Supramolecular Congo Red and Congo Red-Doxorubicin Complexes with Proteins for Drug Carrier Design.

Authors:  Anna Jagusiak; Katarzyna Chłopaś; Grzegorz Zemanek; Izabela Kościk; Irena Roterman
Journal:  Pharmaceutics       Date:  2021-11-28       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.